Proteovant Therapeutics
0 followers
‌
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.
Industries
+1
Headquarters
Employees
Links
Org chart
Drew Fromkin
CEO
Drew Fromkin
Collapse
Zhihua Sui
Chief Scientific Officer
Helai Mohammad
VP, Biology
Winston Wu
VP, CMC
Larry J. Jolivette
VP, DMPK
Corey Strickland
VP, Molecular Technology
Christine Stuhlmiller
VP, Program Management
Ruby Holder
Chief Strategy Officer
Steven Knight
Senior Director, Medicinal Chemistry
